Search research articles
Contact Us
Filters
Showing results (81-90 of 119) with videos related to
Page
of 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2019
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study
A Le Cesne, P Marec-Berard, J-Y Blay, et al.
Oncogene
|
November 17, 2005
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas
B Ballester, O Ramuz, C Gisselbrecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, et al.
ESMO Open
|
June 7, 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
A Le Cesne, C Chevreau, C Perrin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group
A T Falk, L Moureau-Zabotto, M Ouali, et al.
Plos One
|
February 25, 2017
Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?
C Honoré, V Atallah, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2025
Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial
N Penel, A Italiano, J Wallet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P Pautier, N Penel, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2014
Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial
A Adenis, J-Y Blay, B Bui-Nguyen, et al.
Bone Marrow Transplantation
|
April 5, 2016
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
L Boudin, A Gonçalves, R Sabatier, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 119) with videos related to
Sort By:
Page
of 12
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2019
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study
A Le Cesne, P Marec-Berard, J-Y Blay, et al.
Oncogene
|
November 17, 2005
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas
B Ballester, O Ramuz, C Gisselbrecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, et al.
ESMO Open
|
June 7, 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
A Le Cesne, C Chevreau, C Perrin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group
A T Falk, L Moureau-Zabotto, M Ouali, et al.
Plos One
|
February 25, 2017
Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?
C Honoré, V Atallah, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2025
Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial
N Penel, A Italiano, J Wallet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P Pautier, N Penel, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2014
Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial
A Adenis, J-Y Blay, B Bui-Nguyen, et al.
Bone Marrow Transplantation
|
April 5, 2016
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
L Boudin, A Gonçalves, R Sabatier, et al.
Page
of 12